Over the past four decades, sperm counts among men worldwide have dropped by more than 50 percent, according to a 2022 meta-analysis published in Human Reproduction Update. The decline is accelerating, and it is not limited to humans. Across agricultural regions and contaminated watersheds, researchers are documenting reproductive failures in livestock, fish, amphibians, and birds. A growing body of peer-reviewed research now points to a common driver: synthetic chemicals that hijack the hormonal signals governing reproduction.
These chemicals, broadly classified as endocrine-disrupting chemicals (EDCs), include widely used pesticides and per- and polyfluoroalkyl substances (PFAS), the so-called “forever chemicals” found in everything from nonstick cookware to firefighting foam. As of May 2026, the evidence linking them to fertility decline spans laboratory experiments, human cohort studies, and cross-species reviews, and it raises pressing questions about whether regulatory systems are equipped to respond.
The evidence across species
The Endocrine Society’s landmark 2009 scientific statement remains one of the most cited documents in the field. That peer-reviewed synthesis drew on decades of experimental animal models, human epidemiologic studies, and clinical observations to establish that EDCs can alter hormonal pathways essential to fertility, fetal development, and reproductive health. Its conclusions have held up and been reinforced by subsequent research.
More recently, a review framed around a One Health approach examined pesticide classes commonly detected in agricultural systems and their effects on reproduction across species. The analysis identified two primary mechanisms of harm: direct endocrine disruption and oxidative stress. Critically, it did not stop at human data. The review documented reproductive dysfunction in humans, livestock, and wildlife, tracing exposure pathways through food, water, and direct contact in farming environments. (Note: the PMC identifier PMC13011801 is unusually high for the PubMed Central archive; readers should verify the link resolves to the intended article.) For agricultural communities, the implications are immediate: the same chemicals applied to boost crop yields may be undermining the reproductive capacity of the people and animals living among them.
On the PFAS front, a population-based cohort study of reproductive-age women in Singapore provided some of the most direct human evidence to date. Researchers measured preconception plasma levels of several PFAS compounds and tracked fertility outcomes. Women with higher blood concentrations experienced longer time-to-pregnancy and reduced likelihood of clinical pregnancy and live birth, with effect sizes increasing across exposure quartiles. Published in Science of the Total Environment, the study represents primary epidemiologic evidence linking measured preconception PFAS levels directly to fertility endpoints in women actively trying to conceive.
U.S. federal agencies have reached similar conclusions through their own assessments. The National Institute of Environmental Health Sciences (NIEHS) has stated that higher blood PFAS levels are associated with reduced likelihood of pregnancy and live birth. The Agency for Toxic Substances and Disease Registry (ATSDR), part of the CDC, confirms that PFAS are widespread in humans and animals globally, with PFOA and PFOS among the most studied compounds. And the Environmental Protection Agency (EPA) has acknowledged that epidemiologic studies suggest exposure to certain PFAS may be associated with decreased fertility, among other adverse health effects.
Where the science is still catching up
The strongest links between toxic chemicals and fertility decline come from controlled laboratory experiments and targeted human cohort studies. What researchers still lack is large-scale, longitudinal wildlife data that tracks population-level reproductive outcomes alongside measured chemical exposures over time. Reports of declining amphibian and fish populations in contaminated areas are consistent with laboratory findings, but direct field measurements in wild species remain sparse. The cross-species narrative, while compelling, still relies partly on inference from controlled settings.
A second major gap involves chemical mixtures. The Singapore cohort study measured PFAS mixtures rather than individual compounds, which is a step toward capturing real-world exposure. But no published study has yet documented the synergistic effects of simultaneous PFAS and pesticide exposure in diverse human populations. Agricultural workers, who encounter both pesticide residues and PFAS-contaminated water, represent an obvious study population, yet the interaction between those exposures has not been isolated in a controlled human study. The existing literature treats these chemical families largely in parallel.
Generational transmission is another area where the science is suggestive but unsettled. Some animal studies indicate that EDC exposure in one generation can impair fertility in offspring, a finding with alarming implications if it holds in humans. Confirming that pattern, however, requires decades of follow-up that most existing cohorts have not yet completed. Researchers are also working to determine which windows of vulnerability, such as fetal development, puberty, or the preconception period, matter most for long-term reproductive outcomes.
Then there is the regulatory question. While the EPA has published its current understanding of PFAS risks, no global treaty or binding agreement specifically addresses the reproductive effects of EDC mixtures. The Stockholm Convention covers certain persistent organic pollutants, but it was not designed to regulate the thousands of EDCs now in commercial use. Domestic regulatory timelines for stricter PFAS limits vary widely across countries, and whether the pace of policy will match the pace of accumulating evidence remains an open and contested question.
Why reading the evidence carefully matters
Not all sources in this field carry equal weight, and the distinction matters for anyone trying to separate signal from noise. The Endocrine Society statement, the Singapore cohort study, and the One Health agricultural review are primary evidence: they present original data, describe methods, and report quantified findings subject to peer review. Agency communications from the ATSDR, NIEHS, and EPA serve a different function. They translate scientific findings into public health guidance, but they are not substitutes for the original studies. When the ATSDR states that PFAS are widespread globally, it is summarizing a body of research, not presenting new measurements.
Correlation and causation also remain a critical distinction. The Singapore study found a dose-response pattern across PFAS quartiles, which strengthens the case for a real biological effect. But an observational cohort study cannot, by design, prove direct causation. Other factors correlated with higher PFAS exposure, such as occupation, diet, or socioeconomic status, might also influence reproductive health. Statistical adjustments reduce but do not eliminate these potential confounders.
What makes the overall case compelling is convergence. When laboratory experiments show that a compound disrupts hormone signaling at exposure levels comparable to those measured in human populations, and epidemiologic studies then find parallel associations in people, and wildlife data point in the same direction, the combined weight of evidence becomes difficult to dismiss. No single study is definitive, but the pattern across methods and species is what has moved many researchers from caution to concern.
What regulators and individuals face now
For policymakers, the central tension is familiar: acting under conditions of incomplete knowledge. Waiting for perfect, multigenerational human data on every compound and mixture would delay interventions for decades. Moving too aggressively on limited evidence carries economic and political costs, particularly in sectors that depend on pesticides or PFAS-containing products. The current approach in most jurisdictions is incremental: phasing out a handful of well-studied chemicals, tightening drinking water standards, and encouraging voluntary industry reductions, while broader questions about mixtures and low-dose effects remain unresolved.
For individuals, especially those planning pregnancies or working in high-exposure settings like agriculture and certain manufacturing industries, the evidence supports practical precaution. That can include discussing exposure risks with healthcare providers, using personal protective equipment where appropriate, following workplace safety protocols, and, where feasible, choosing food and water sources less likely to carry heavy contamination. None of these steps can eliminate contact with chemicals that are now ubiquitous in the environment, but they may reduce the highest and most preventable doses.
Reproductive health as an environmental issue
The accumulating research on EDCs, PFAS, and fertility points toward a conclusion that public health systems have been slow to absorb: reproductive health is not separate from environmental conditions. Protecting one increasingly requires addressing the other. As data continue to build across human, livestock, and wildlife studies, the picture will likely sharpen. For now, the weight of the best available evidence argues that synthetic chemicals capable of disrupting hormones deserve sustained scientific scrutiny, transparent communication of what is known and what is not, and regulatory frameworks nimble enough to adapt as the science evolves.
More from Morning Overview
*This article was researched with the help of AI, with human editors creating the final content.
